Chronopharmacology of glucocorticoids.

Abstract

Glucocorticoids influence a wide array of metabolic, anti-inflammatory, immunosuppressive, and cognitive signaling processes, playing an important role in homeostasis and preservation of normal organ function. Synthesis is regulated by the hypothalamic-pituitary-adrenal (HPA) axis of which cortisol is the primary glucocorticoid in humans. Synthetic glucocorticoids are important pharmacological agents that augment the anti-inflammatory and immunosuppressive properties of endogenous cortisol and are widely used for the treatment of asthma, Crohn's disease, and rheumatoid arthritis, amongst other chronic conditions. The homeostatic activity of cortisol is disrupted by the administration of synthetic glucocorticoids and so there is interest in developing treatment options that minimize HPA axis disturbance while maintaining the pharmacological effects. Studies suggest that optimizing drug administration time can achieve this goal. The present review provides an overview of endogenous glucocorticoid activity and recent advances in treatment options that have further improved patient safety and efficacy with an emphasis on chronopharmacology.

• Authors: Megerle L Scherholz, Naomi Schlesinger, Ioannis P Androulakis
• Journal: Advanced drug delivery reviews (Adv Drug Deliv Rev) 2019 Nov - Dec Vol. 151-152 Pg. 245-261 ISSN: 1872-8294 [Electronic] Netherlands
• PMID: 30797955 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
• Copyright: Copyright © 2019. Published by Elsevier B.V.

Chemical References

• Glucocorticoids

Topics

• Animals
• Drug Delivery Systems
• Glucocorticoids (administration & dosage, chemistry, pharmacology)
• Humans